In 2003, the MOPH published a first National Essential ... · هماع تحص تراو Ministry of Public Health یوجلاعم بط یمومع تسایر General Directorate of Curative

زارت صحت عامهو

Ministry of Public Health یطب معالجو یاست عمومیر

General Directorate of Curative Medicine

مرکز یاست شفاخانه هایر

Directorate of Central Hospitals

نید معلولمجد یایاست شفاخانه احیر

Rehabilitation of Disabled Hospital

یومعالجو یته دوائیکم

Drug & Therapeutics Committee

یلست فورمولر

Formulary List

June 2015

ن یمجدد معلول یایشفاخانه اح یرفورمول لست

Page 3 نیمجدد معلول یایشفاخانه اح یومعالجو ییته دواید شده توسط کمیتائ

ACRONYMS

ATC Anatomical Therapeutic Chemical

mcg Micro gram

g Gram

IU International Units

L Liter

mg Milligram

ml Milliliter

MU Million units

IV Intravenous

kg Kilo gram

cm Centimeter

m2 Square meter

Vit Vitamin



ANATOMO-THERAPEUTIC-CHEMICAL (ATC) CLASSIFICATION

A- ALIMENTARY TRACT AND METABOLISM

A02- DRUGS FOR ACID RELATED DISORDERS A02A- ANTACIDS

Aluminium hydroxide + Magnesium hydroxide Chewable tablet: 200 mg + 200 mg

Aluminium hydroxide +Magnesium hydroxide Oral Suspension: 225mg+200 mg in 200 ml

A02B - DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

Esomeprazole Capsule: 40 mg Esomeprazole Capsule: 20 mg

Famotidine Tablet: 40 mg

Omeprazole Capsule: 20 mg

Ranitidine Tablet: 150 mg

A03- DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS A03B -BELLADONNA AND DERIVATIVES, PLAIN

Hyoscine (butylbromide, hydrobromide) Tablet: 10 mg

Hyoscine (butylbromide, hydrobromide) Injection ampoule: 20 mg/ml, in 1 ml A03F- PROPULSIVES

Domperidone Tablet: 10 mg

Metoclopramide Tablet: 10 mg

Metoclopramide Injectable solution: 5 mg/ml in 2 ml ampoule

A06- LAXATIVES

A06A—LAXATIVES

Bisacodyl Tablet: 5 mg

A07- ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE A07A- INTESTINAL ANTIINFECTIVES

Nystatin Oral topical drop: 100,000 IU



A07C- ELECTROLYTES WITH CARBOHYDRATES

Oral Rehydration Salts (ORS) Oral Powder: 27.9 g/L in 1 L Sachet

A10. DRUGS USED IN DIABETES A10B- BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS

Glibenclamide Tablet: 5 mg

Metformin Tablet: 500 mg

A11. VITAMINS A11A - MULTIVITAMINS, PLAIN

Multivitamins and other minerals Tablet

A11B—MULTIVITAMINS, PLAIN

Multivitamins Tablet

A11C- VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO

Colecalciferol (Vit D3) Injection ampoule: 600,000 IU/ml

Retinol (Vit A) Tablet: 100,000 IU

Calcium Phosphate + Vitamin D Syrup: 210 mg + 350 IU/5 ml, in 110 ml

A11G- ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS

Ascorbic Acid (Vit C) Tablet: 500 mg

A11H – OTHER PLAIN VITAMIN PREPARATION

Pyridoxine (Vitamin B6) Tablet: 25 mg

A12- MINERAL SUPPLEMENTS A12A - CALCIUM

Calcium gluconate Injectable solution: 10%, in 10 ml ampoule

B- BLOOD AND BLOOD FORMING ORGANS

B01- ANTITHROMBOTIC AGENTS B01A—ANTITHROMBOTIC AGENTS

Acetylsalicylic acid (Aspirin) (ASA) Tablet: 100 mg

Clopidogrel Tablet: 75 mg



B03- ANTIANEMIC PREPARATIONS B03A- IRON PREPARATIONS

Ferrous sulfate (strength in Fe equivalent) + Folic acid Tablet: 60 mg + 0.4 mg

B03B. VITAMIN B12 AND FOLIC ACID

Folic acid (Vit B9) Tablet: 5 mg

Hydroxocobalamine (Vit B12) Injectable Ampoule: 0.5 mg/ml, in 1 ml

Mecobalamine (Vit B12) Tablet: 500 mg

B05- BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS B05B- I.V. SOLUTIONS

Glucose + Sodium chloride Injectable solution: 5% + 0.9%, in 500 ml bottle

Glucose + Sodium chloride Injection solution: 5% +0.9%, in 1000 ml bottle

Sodium chloride Injectable solution: 0.9%, in 500 ml bottle

Sodium chloride Injectable solution: 0.9%, in 1000 ml bottle

Ringer lactate Injectable solution: in 500 ml bottle

Ringer lactate Injectable solution: in 1000 ml bottle

B05C- IRRIGATING SOLUTIONS

Glucose Injectable solution: 5%, in 500 ml bottle




C- CARDIOVASCULAR SYSTEM

C02- ANTIHYPERTENSIVES C02A- ANTIADRENERGIC AGENTS, CENTRALLY ACTING

Methyldopa Tablet: 250 mg C03- DIURETICS C03A- LOW-CEILING DIURETICS, THIAZIDES

Hydrochlorothiazide Tablet: 25 mg

Hydrochlorothiazide Tablet: 50 mg

C03C- HIGH-CEILING DIURETICS

Furosemide Tablet: 40 mg

Furosemide Tablet: 20 mg



C07- BETA BLOCKING AGENTS C07A- BETA BLOCKING AGENTS

Atenolol Tablet: 100 mg

Propranolol Tablet: 10 mg

C08- CALCIUM CHANNEL BLOCKING AGENTS C08c- SELECTIVE CALCIUMCHANNEL BLOCKING MAINLY WITH VASCULAR EFFECTS

Amlodipine Tablet: 5 mg

Nifedipine Tablet: 10 mg

C09- AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM C09A- ACE INHIBITORS, PLAIN

Captopril Tablet: 25 mg

C10. LIPID MODIFYING AGENTS C10A. LIPID MODIFYING AGETNTS, PLAN

Atorvastatin Tablet: 20 mg

Fenofibrate Tablet: 200 mg

D- DERMATOLOGICALS

D04- ANTIPRURITICS, INCLUDING ANTIHSTAMINES, ANESTHETICS D04A—ANTIPRURITICS, INCLUDING ANTIHISTAMINES, ANESTHETICS, AND OTHERS

Lidocaine Topical cream: 2%

D06B- CHEMOTHERAPEUTICS FOR TOPICAL USE

Silver sulfadiazine Topical cream: 1% in 20 gr

D08- ANTISEPTICS AND DISINFECTANTS D08A—ANTISEPTICS AND DISINFECTANTS

Chlorhexidine digluconate Topical Solution: 5%

Hydrogen peroxide Topical Solution: 6%

Chloroxylenol Topical Solution: 4.8%

Povidone iodine Topical Solution: 10%

Chlorine Topical Solution: 0.5%

Ethanol Topical Solution: 70%



D11—OTHER DERMATOLOGICAL PREPARATIONS D11A—OTHER DERMATOLOGICAL PREPARATIONS

Diclofenac Topical Gel: 1%, in 20 gr

H- CORTICOSTEROIDS FOR SYSTEMIC USE

H02A- CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN

Betamethasone Injectable Solution: 4 mg/ml, in 1 ml

Dexamethasone Injectable Solution: 4mg/ml, in 2 ml ampoule

Dexamethasone Tablet: 0.5 mg

Hydrocortisone sodium succinate Injectable Solution: 100 mg/vial

Methylprednisolone Injectable Solution: 40 mg/ml, in 2 ml ampoule

Prednisolone Tablet: 5 mg

J- ANTIINFECTIVES FOR SYSTEMIC USE

J01- ANTIBACTERIALS FOR SYSTEMIC USE J01A- TETRACYCLINES

Doxycycline Capsule: 100 mg

J01B- AMPHENICOLS

Chloramphenicol Injectable Solution: 1g/vial

J01C- BETA-LACTAM ANTIBACTERIALS, PENICILLINS

Amoxicillin Oral suspension: 125 mg/5 ml in 60 ml

Amoxicillin Oral suspension: 250 mg/5 ml in 60 ml

Amoxicillin Capsule: 250 mg

Amoxicillin Capsule: 500 mg

Amoxicillin + Clavulanic acid (Co-amoxiclav) Tablet: 500 mg + 125 mg

Ampicillin Injectable powder: 500 mg/vial

Ampicillin Injectable powder: 1g/vial

Ampicillin + cloxacillin Tablet: Capsule: 250 mg + 250 mg

Cloxacillin Tablet: Capsule: 250 mg

Cloxacillin Tablet: Capsule: 500 mg

Penicillin Benzyl Benzathine Injectable solution: 1.2 MU/vial



J01D- OTHER BETA-LACTAM ANTIBACTERIALS

Ceftriaxone Injectable powder: 500 mg/vial

Ceftriaxone Injectable powder: 1g/vial

Cefixime Tablet: 200 mg

Cefixime Tablet: 400 mg

Cefixime Oral suspension: 100 mg/5 ml in 30 ml

Cefixime Oral suspension: 200 mg/5 ml in 30 ml

J01E- SULFONAMIDES AND TRIMETHOPRIM

Sulfamethoxazole + Trimethoprim (Cotrimoxazole) Tablet: 400 mg + 80 mg

Sulfamethoxazole + Trimethoprim (Cotrimoxazole) Oral suspension: 200 mg+40 mg/5 ml in 50 ml

J01F- MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS

Azithromycin Capsule: 250 mg

Azithromycin Capsule: 500 mg

Clarithromycin Tablet: 250 mg

Erythromycin (stearate) Tablet: 250 mg

Erythromycin (stearate) Tablet: 500 mg

J01G- AMINOGLYCOSIDE ANTIBACTERIALS

Amikacin Injectable Solution: 250 mg/1 ml, in 2 ml

Gentamicin Injectable Solution: 40 mg/ml, in 2 ml

J01M- QUINOLONE ANTIBACTERIALS

Ciprofloxacin Tablet: 250 mg



Gatifloxacin Tablet: 200 mg

Gatifloxacin Tablet: 400 mg

Levofloxacin Tablet: 250 mg

Levofloxacin Tablet: 500 mg

Ofloxacin Tablet: 200 mg

Ofloxacin Tablet: 400 mg

Nalidixic Acid Tablet: 250 mg

Nalidixic Acid Tablet: 500 mg

J01X-OTHER ANTIBACTERIALS

Nitrofurantoin Tablet: 100 mg



M- MUSCULO-SKELETAL SYSTEM

M01- ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS M01A- ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS

Celecoxib Capsule: 100 mg

Celecoxib Capsule: 200 mg

Diclofenac (sodium or potassium) Tablet: 50 mg

Diclofenac (sodium or potassium) Tablet: 75 mg

Diclofenac Injection: 25 mg/ml, in 3 ml

Ibuprofen Tablet: 200 mg

Ibuprofen Tablet: 400 mg

Ibuprofen Syrup: 100 mg/5 ml in 60 ml

Indomethacin Tablet: 75 mg

Indomethacin Injectable solution: 37.5 mg/ml in 2 ml

Ketoprofen Tablet: 100 mg

Ketoprofen Tablet: 200 mg

Meloxicam Tablet: 7.5 mg

Meloxicam Tablet: 15 mg

Naproxen Tablet: 250 mg

Naproxen Tablet: 550 mg

Nimesulide Tablet: 100 mg

Piroxicam Capsule: 20 mg

Piroxicam Injectable solution: 10 mg/ml, in 2 ml

Piroxicam Topical Gel: 0.5%

M03—MUSCLE RELAXANTS M03B—MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS

Orphenadrine + Paracetamol Tablet: 35mg + 450 mg

N - NERVOUS SYSTEM

N01. ANESTHETICS N01B- ANESTHETICS, LOCAL

Lidocaine Injectable solution: 2%, in 2 ml ampoule

Adrenalin + Lidocaine Injectable solution: 0.00125% + 1%

Adrenalin + Lidocaine dental Injectable solution: 0.00125% + 2%



N02- ANALGESICS

N02A- OPIOIDS

Tramadol Tablet: 50 mg

N02B—OTHER ANALGESICS AND ANTIPYRETICS

Acetylsalicylic acid (Aspirin) Tablet: 500 mg

Paracetamol (Acetaminophen) Tablet: 500 mg

Paracetamol (Acetaminophen) Syrup: 120 mg/5 ml

Paracetamol (Acetaminophen) Rectal Suppository: 125 mg

N03- ANTIEPILEPTICS

N03A—ANTIEPILEPTICS

Carbamazepine Tablet: 100 mg

Magnesium sulfate Injectable solution: 500mg/ml in 10 ml ampoule

Phenobarbital Tablet: 100 mg

Phenobarbital Tablet: 15 mg

Valproic acid Tablet: 250 mg

N04- ANTI-PARKINSON MEDICINES

N04A- ANTICHOLINERGIC AGENTS

Trihexyphenidyl Tablet: 2 mg

N05- PSYCHOLEPTICS

N05B. ANXIOLYTICS

Alprazolam Tablet: 0.5 mg

Diazepam Tablet: 10 mg



N06- PSYCHOANALEPTICS

N06A- ANTIDEPRESSANTS

Amitriptyline Tablet: 25 mg

Fluoxetine Capsule: 20 mg

Imipramine Tablet: 10 mg



P- ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

P01- ANTIPROTOZOALS P01A- AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES

Metronidazole Tablet: 200 mg

Metronidazole Tablet: 400 mg

Metronidazole Syrup: 200 mg/5 ml in 60 ml bottle

P01B- ANTIMALARIALS

Chloroquine (base) Tablet: 150 mg

P02- ANTHELMINTICS P02C—ANTINEMATODAL AGENTS

Albendazole Chewable tablet: 200 mg

Albendazole Chewable tablet: 400 mg

Mebendazole Tablet: 100 mg

R- RESPIRATORY SYSTEM

R01. NASAL PREPARATIONS R01A- DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL

Naphazoline Nasal drop: 0.05% in 10ml bottle

Sodium chloride Nasal drop: 0.65%, in10 ml bottle

R03- DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES R03A- ADRENERGICS, INHALANTS

Salbutamol Inhalation solution: 0.1mg/ dose, in 200 dose bottle

Beclometasone dipropionate Inhalation aerosol: 250 mcg per dose

R03C- ADRENERGICS FOR SYSTEMIC USE

Salbutamol Tablet: 2 mg

Salbutamol Tablet: 4 mg

Salbutamol Syrup: 2 mg/5 ml in 60ml bottle

R03D- OTHER SYSTEMIC MEDICINES FOR OBSTRUCTIVE AIRWAY DISEASES

Aminophylline Injectable solution: 25 mg/ml, in 10 ml

Aminophylline Tablet: 100 mg



R06- ANTIHISTAMINES FOR SYSTEMIC USE R06A- ANTIHISTAMINES FOR SYSTEMIC USE

Chlorphenamine maleate Tablet: 4 mg

Dimenhydrinate Tablet: 50 mg

Diphenhydramine chloride Syrup: 5 mg/ ml in 60ml

Promethazine Tablet: 25 mg

Loratadine Tablet: 10 mg

S- SENSORY ORGANS

S01- OPHTHALMOLOGICALS S01A- EYE ANTI-INFECTIVES

Chloramphenicol Ophthalmic drop 0.5% in 2.5 ml bottle

Tetracycline Ophthalmic ointment: 1% in 5g tube

Bacitracin Ophthalmic ointment: 500 IU/g, in 3.5 g tube

S01B- EYE ANTI-INFLAMMATORY

Prednisolone acetate Ophthalmic drop: 0.5%, in 5 ml bottle

Prednisolone acetate Ophthalmic drop: 1%, in 5 ml bottle

S01H- EYE LOCAL ANESTHETIC

Tetracaine Ophthalmic drop: 0.5% in15 ml bottle

SO2A – EYE ANTIINFCTIVES

Boric acid + glycerin 5% (glycerin boric) Otic liquid: 5% in 10 ml

V07- ALL OTHER NON-THERAPEUTIC PRODUCTS V07A—ALL OTHER NONTHERAPEUTIC PRODUCTS

Water for Injection Injectable solution: 10 ml ampoule

Water for Injection Injectable solution: 5 ml ampoule



APPENDIX A. BODY SURFACE AREA AND MEDICINE DOSAGE

______________________

Body surface area in m2 = √ {height (cm) x weight (kg)}

3600 Thus a child weighing 10 kg and 72 cm long has a body surface area of

45.00)(10x72/360

Table A1. Drug Dosage by surface area (m2) of the child

Age or weight of child Surface area ________________________________________________

Neonate (< 1 month) 0.2–0.25 m2 ________________________________________________

Young infant (1–<3 months) 0.25–0.35 m2 ________________________________________________

Child 5–9 kg 0.3–0.45 m2 ________________________________________________

Child 10–14 kg 0.45–0.6 m2 ________________________________________________

Child 15–19 kg 0.6–0.8 m2 ________________________________________________

Child 20–24 kg 0.8–0.9 m2 ________________________________________________

Child 25–29 kg 0.9–1.1 m2 ________________________________________________

Child 30–39 kg 1.1–1.3 m2 ________________________________________________

Note: Example if the recommended dose is given as 400 mg/m2 twice per day,

then a child in the weight range of 15–19 kg should receive the recommended dose of

(0.6–0.8) x 400 = 244–316 mg twice per day

Source: Hospital Care for Children, World Health Organization



APPENDIX B. COMPARISON OF PERCENTAGE WITH RATIO, TEMPERATURE,

WEIGHT, VOLUME, LENGTH

Length

1 meter = 100 centimeters = 1,000 millimeters 10 millimeters = 1 centimeter

Temperature Conversion

°C x 9/5 + 32 = °F

(°F − 32) x 5/9 = °C

Weight

1 gram = 1,000 milligrams

1 milligram = 1,000 micrograms

1 kilogram = 1,000 grams

1 kilogram = 2.2 pounds

1 pound = 6 ounces

Comparison of Percentage and Ratio

1:100 1:200

= 1g/100ml [10mg/ml] = 500mg/100ml [5mg/ml]

= 1%

= 0.5%

1:1,000 1:5,000

= 100mg/100ml [1mg/ml] = 20mg/100ml [200mcg/ml]

= 0.1%

= 0.02%

1:10,000 = 10mg/100ml [100mcg/ml] = 0.01%



1 liter 1,000 milliliters

1 quart / 32 ounces / 2 pints 500 milliliters

1 pint / 16 ounces / 2 cups 240 milliliters

1 cup / 8 ounces 30 milliliters

1 ounce 15 milliliters

1 tablespoon / 3 teaspoons 5 milliliters

15 drops 0.0667 milliliters

1 drop

Source: Simmers, Louise. Diversified Health Occupations (OR

Introduction to Health Science Technology). Delmar, Latest edition.

Volume

1,000 cubic millimeters = 1 cubic centimeter

1,000 cubic centimeters = 1 cubic decimeter

1,000 cubic decimeters = 1 cubic meter

10 deciliters = 1 liter

1 liter = 1,000 milliliters

10 centiliters = 1 deciliter



APPENDIX C. WEIGHT PER HEIGHT

Height Estimated Lean Body Weight

(+) or ( - ) 2.3 kg per inch over/under 5 feet tall (+) 50 kg for men or (+) 45.5 kg for women

Imperial / metric Males (kg) Females (kg)

4 ft 8 in / 142 cm 40.8 36.3

4 ft 9 in / 145 cm 43.1 38.6

4 ft 10 in / 147 cm 45.4 40.9

4 ft 11 in / 150 cm 47.7 43.2

5 ft 0 in / 152 cm 50.0 45.5

5 ft 1 in / 155 cm 52.3 47.8

5 ft 2 in / 157 cm 54.6 50.1

5 ft 3 in / 160 cm 56.9 52.4

5 ft 4 in / 163 cm 59.2 54.7

5 ft 5 in / 165 cm 61.5 57.0

5 ft 6 in / 168 cm 63.8 59.3

5 ft 7 in / 170 cm 66.1 61.6

5 ft 8 in / 173 cm 68.4 63.9

5 ft 9 in / 175 cm 70.7 66.2

5 ft 10 in / 178 cm 73.0 68.5

5 ft 11 in / 180 cm 75.3 70.8

6 ft 0 in / 183 cm 77.6 73.1

6 ft 1 in / 185 cm 79.9 75.4

6 ft 2 in / 188 cm 82.2 77.7

6 ft 3 in / 191 cm 84.5 80.0

6 ft 4 in / 193 cm 86.8 82.3

6 ft 5 in / 196 cm 89.1 84.6

6 ft 6 in / 198 cm 91.4 86.9

6 ft 7 in / 201 cm 93.7 89.2

6 ft 8 in / 203 cm 96.0 91.5



INDEX A

Acetylsalicylic acid (Aspirin) (ASA) [B01A; N02B]

Adrenalin + Lidocaine [N01B]

Albendazole [P02C]

Aluminium hydroxide + Magnesium hydroxide [A02A]

Alprazolam [N05B]

Amikacin [J01G]

Aminophylline [R03D]

Amitriptyline [N06A]

Amoxicillin [J01C]

Amoxicillin + Clavulanic acid (Co-amoxiclav) [J01C]

Ampicillin [J01C]

Ampicillin + Cloxacillin [J01C]

Amlodipine [C08]

Ascorbic Acid (Vit C) [A11G]

Atenolol [C07A]

Atorvastatin [C10A]

Azithromycin [J01F]

B Bacitracin [S01A]

Beclometasone dipropionate [R03]

Betamethasone [H02A]

Bisacodyl [A06]

Boric acid + glycerin [S02A]

C

Calcium Gluconate [A12A]

Calcium Phosphate + Vitamin D [A11C]

Captopril [C09A]

Carbamazepine [N03]

Cefixime [J01D]

Ceftriaxone [J01D

Celecoxib [M01A]

Chlorine [D08]

Chloramphenicol [J01B; S01A]

Chlorhexidine digluconate [D08A]

Chloroquine (base) [P01B]

Chlorphenamine maleate [R06A]

Chloroxylenol [D08A]

Ciprofloxacin [J01M]

Clarithromycin [J01F]

Clopidogrel [B01A]



Cloxacillin [J01C]

Colecalciferol (Vit D3) [A11C]

D Dexamethasone [H02A]

Diazepam [N05B]

Diclofenac [D11A; M01A]

Dimenhydrinate [R06A]

Diphenhydramine chloride [R06A]

Domperidone [A03F]

Doxycycline [J01A]

E

Erythromycin stearate [J01F]

Esomeprazole [A02B]

Ethanol 70% [D08]

F

Famotidine [A02B]

Ferrous sulfate (strength in Fe equivalent) + Folic acid [B03A]

Fenofibrate [C10]

Fluoxetine [NO6A]

Folic Acid (Vit B9) [A11H]

Furosemide [C03C]

G

Gatifloxacin [J01M]

Gentamicin [J01G;]

Glucose [B05C]

Glucose + Sodium chloride [B05B]

Glibenclamide [A10B]

H

Hydrochlorothiazide [C03A]

Hydrocortisone sodium succinate [H02A]

Hydrogen peroxide [D08]

Hydroxocobalamine (Vit B12) [B03B]

Hyoscine (butylbromide, hydrobromide) [A03B]

I

Ibuprofen [M01A]

Imipramine [NO6A]

Indomethacin [M01A]



K

Ketoprofen [M01A]

L

Levofloxacin [J01M]

Lidocaine [D04A]; N01B]

Loratadine [R06A]

M

Magnesium sulfate [N03A]

Mebendazole [P02C]

Mecobalamine (Vit B12) [B03B]

Meloxicam [M01A]

Metformin [A10B]

Methyldopa [C03A]

Methylprednisolone [H02A]

Metoclopramide [A03F]

Metronidazole [P01A]

Multivitamins and other minerals [A11A]

Multivitamins [A11B]

N

Nalidixic Acid [J01M] Naproxen [M01A]

Naphazoline [RO1]

Nifedipine [C08]

Nimesulide [M01A]

Nitrofurantoin [J01X]

Nystatin [A07A]

O

Ofloxacin [J01M]

Omeprazole [A02B]

Oral rehydration salts (ORS) [A07C]

Orphenadrine + Paracetamol [M03B]

P

Paracetamol (Acetaminophen) [N02B]

Penicillin Benzyl Benzathine [J01C]

Phenobarbital [N03A]

Piroxicam [M01A]



Povidone iodine [D08A]

Prednisolone [H02A; S01B]

Promethazine [R06A]

Propranolol [C07A]

Pyridoxine (Vit B6) [A11H]

R

Ranitidine [A02B]

Retinol (Vit A) [A11C]

Ringer lactate [B05B]

S

Salbutamol [R03A; R03C]

Silver sulfadiazine [D06B]

Sodium chloride [B05B; R01A]

Sulfamethoxazole + Trimethoprim (Cotrimoxazole) [J01E]

T Tetracaine [S01H]

Tetracycline [S01A]

Tramadol [N02A]

Trihexyphenidyl [B02A]

V Valproic acid [N03]

W Water for Injection [V07A]

In 2003, the MOPH published a first National Essential ... · هماع تحص تراو Ministry of Public Health یوجلاعم بط یمومع تسایر General Directorate of Curative

Documents